Mediator release of neuropeptiDes after nasal provocation in perennial allergic rhinitis patients

Rhinology

Volumn 48, Issue 2, 2010, Pages 206-210

  Gawlik, Radoslaw ^a   DuBuske, Lawrence ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Immunology Research Institute of New England   (United States)

Author keywords

Bradykinin; Nasal lavage fluid; Substance P

Indexed keywords

ALLERGEN; BRADYKININ; NEUROPEPTIDE; SUBSTANCE P;

ADULT; ANIMAL; ARTICLE; CASE CONTROL STUDY; CHEMISTRY; FEMALE; HUMAN; IMMUNOLOGY; MALE; NONPARAMETRIC TEST; NOSE MUCUS; NOSE PROVOCATION TEST; PERENNIAL RHINITIS; PYROGLYPHIDAE;

ALLERGENS; ANIMALS; BRADYKININ; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; NASAL LAVAGE FLUID; NASAL PROVOCATION TESTS; NEUROPEPTIDES; PYROGLYPHIDAE; RHINITIS, ALLERGIC, PERENNIAL; STATISTICS, NONPARAMETRIC; SUBSTANCE P; YOUNG ADULT;

EID: 77952969951     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: 10.4193/Rhin09.111     Document Type: Article

References (28)

1. Naclerio RM, Proud D, Togias AG, et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985; 11: 65-70.
2. Mosimann BL, White MV, Hohman RJ, et al. Substance P, calcitonin gene-related peptiDe, and vasoactive intestinal peptiDe increase in nasal secretions after allergen challenge in atopic patients. J Allergy Clin Immunol. 1993; 92: 95-104.
3. Naclerio RM, Meier HL, Kagey-Sobotka A, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983; 72: 597-602.
4. Freeland HS, Pipkorn U, Schleimer RP, et al. Leucotriene B4 as mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo. Am Rev Respir Dis 1989; 83: 634-642.
5. Rahman MA, Inue T, Kamei C. Role of substance P in allergic nasal symptoms in rats. Eur J Pharmacol 2006; 532: 155-161.
6. Luts A, Uddman R, Alm P, et al. PeptiDe-containing nerve fibers in human airways: distribution and coexistence pattern. Int Arch Allergy Immunol 1993; 101: 52-60.
7. Petersson G, Ekman R, Malm L. Substance P and calcitoninegene related peptiDe in nasal secretions after antigen challenge in man. Am J Rhinol 1990; 4:163-167
8. Baraniuk JN, Kaliner MA. NeuropeptiDes and nasal secretion. J Allergy Clin Immunol 1990; 86: 620-627.
9. Nieber K, Baumgarten K, Witzel A, et al. The possible role of substance P in the allergic reaction, based on two different provocation moDels. In Arch Allergy Appl Immunol. 1991; 94: 334-338.
10. Tomaki M, Ichinose M, Miura M, et al. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med 1995; 151: 613-617.
11. Heaney LG, Cross LJM, Stanford CF, et al. Substance P induces histamine release from human pulmonary mast cells. Clin Exp Allergy 1995; 25: 179-186.
12. Forsythe P, McGarvey LPA, Heaney LG, et al. Sensory neuropeptiDes induce histamine release from bronchoalveolar lavage cells in both nonasthmatic coughers and cough variant asthma. Clin Exp Allergy 2000; 30: 225-232.
13. Sheahan P, Walsh RW, Walsh MA, Costello RW. Induction of nasal hyper-responsiveness by allergen challenge in allergic rhinitis: the role of afferent and efferent nerves. Clin Exp Allergy 2005; 35: 45-51.
14. Naclerio RM, Meier HL, Kagey-Sobotka A, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983; 72: 597-602
15. Proud D, Togias A, Naclerio RM, et al. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest.1983; 72:1678-1685
16. Pang L, Knox AJ. Bradykinin stimulates IL-8 production in cultured human airway smooth muscle cells: role of cyclooxygenase products. J Immunol. 1988; 161:2509-2515.
17. Koyama S, Sato E, Nomura H, et al. Bradykinin stimulates type II alveolar cells to release neutrophil and monocyte chemotactic activity and inflammatory cytokines. Am J Pathol .1998; 153: 1885-1893. (Pubitemid 28550675)
18. Douglass JA, Dhami D, Gurr CE, et al. Influence of interleukin-8 challenge in the nasal mucosa in atopic and nonatopic subjects. Am J Respir Crit Care Med. 1994; 150:1108-1113.
19. Turner P, Dear J, Scadding G, et al. Role of kinins in a seasonal allergic rhinitis: Icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen. J Allergy Clin Immunol 2001; 107: 105-113.
20. Maruo K, Akaike T, Matsumura Y, et al. Triggering of the vascular permeability reaction by activation of the Hagemann factorprekallikrein system by house dust mite proteinase. Biochim Biophys Acta 1991; 1074: 62-68.
21. Chuaychoo B, Hunter DD, Myers AC, et al. Allergen -induced substance P synthesis in large-diameter sensory neurons innervating the lungs. J Allergy Clin Immunol 2005; 116: 325-331.
22. Meyers AC, Kajecar R, UnDem BJ. Allergic inflammationinduced neuropeptiDe production in rapidly adapting afferent nerves in guinea pig airway. Am J Physiol Lung Cell Mol Physiol 2002; 282: 775-781.
23. Marshal JS, Waserman S. Mast cells and the nerves- potential interactions in the context of chronic disease. Clin Exp Allergy 1995; 25: 102-110
24. Neet KE, Campenot RB. Receptor binding, internalization, and retrograDe transport of neurotrophic factors. Cell Mol Life Sci 2001; 58: 1021-1035.
25. Ishiura Y, Fujimura M, Myou S, et al. Airway eosinophil accumulation on sensory neuropeptiDe release in guinea pig moDel of Destilled-water-induced bronchoconstriction. J Investig Allergol Clin Immunol 2003; 13: 79-86.
26. Nieber K, Baumgarten K, Ratsack R, et al. Substance P and β-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J Allergy Clin Immunol. 1992; 90: 646-652.
27. Hanf G., Schierhorn K, Brunee T, et al. Substance P induced histamine release from nasal mucosa of subjects with and without allergic rhinitis. Inflamm Res. 2000; 49: 520-523.
28. Joos GD, Germonpre PF, Pauwels RA. Role of tachykinin in asthma. Allergy 2000; 55: 321-337.